Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating encouraging results in the management of type 2 diabetes. This artificial peptide duplicates the actions of naturally occurring GLP-1, a hormone that plays a crucial role in controlling blood insulin response. By stimulating GLP-1 receptors in the pancreas, Retasturtid